PMGC (ELAB) vs Silo Pharma (SILO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Silo Pharma is the larger company by market cap ($3.0 million vs $2.5 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAB | SILO |
|---|---|---|
| Share price | $3.13 | $1.45 |
| Market cap | $2.53M | $2.98M |
| 1-day change | -2.04% | +0.69% |
| EPS (TTM) | $-1,748.36 | $-4.26 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2,671.20 | $10.44 |
| 52-week low | $2.59 | $1.30 |
| Distance from 52-week high | -99.88% | -86.11% |
| Average volume | 140.44K | 114.43K |
| Shares outstanding | 809.58K | 2.05M |
| Employees | 32 | 3 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Healthcare · Biotechnology · 32 employees
About Silo Pharma
SILO stock →Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company.
Healthcare · Biotechnology · 3 employees
ELAB vs SILO FAQ
Which is bigger, PMGC or Silo Pharma?
Silo Pharma (SILO) is larger, with a market capitalization of $2.98M compared with $2.53M for PMGC (ELAB).
Are PMGC and Silo Pharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.